Table of Contents Table of Contents
Previous Page  14 / 89 Next Page
Information
Show Menu
Previous Page 14 / 89 Next Page
Page Background

Volume 6, Issue 6(Suppl)

J Clin Toxicol 2016

ISSN: 2161-0495, JCT an open access journal

Page 46

Notes:

Euro Toxicology 2016

October 24-26, 2016

conferenceseries

.com

Toxicology & Applied Pharmacology

October 24-26, 2016 Rome, Italy

7

th

Euro-Global Summit on

Characterization and regulation of the expression of drug transporters in human skin

Hanan Osman Ponchet

DMPK Research, France

M

ost identified drug transporters belong to ATP-binding cassette (ABC) and solute carrier (SLC) families. It has

been recently recognized that like drug metabolizing enzymes, some of drug transporters play an important role in

pharmacokinetics and drug exposure and may be involved in clinically relevant drug-drug interactions for systemic drugs.

However very little is known about the role of drug transporters in human skin in the disposition of topically applied drugs.

Expression profile of SLC and ABC transporters included in the regulatory guidelines as the most likely clinical sources of

drug interactions was characterized in

ex vivo

human skin using TaqMan real-time RT-PCR. Moreover, the effect of rifampicin

treatment and solar simulator irradiation on the expression of drug transporters in human skin was investigated as well as the

localization of the drug transporters within the different layers of human skin. SLC and ABC transporters have a very specific

expression profile in human skin compared to liver and kidney. In addition, expression of ABCC1 (MRP1) and SLC47A1/2

(MATE1 and MATE2) is shown for the first time in human skin. The role of drug transporters in drug absorption in human

skin will be presented and discussed.

Biography

Hanan Osman Ponchet has completed her PhD from University of Burgundy (France) and Post-doctoral studies from University Hospital of Geneva (Switzerland)

and National Institute of Agronomy Research (France). She is currently Metabolism Manager in the Department of Drug Metabolism and Pharmacokinetics at

Galderma, a global dermatology company. She has more than 15 years of experience in DMPK and has published more than 30 research publications and patents,

and has given invited oral presentations at several different scientific conferences.

hanan.osman-ponchet@galderma.com

Hanan Osman Ponchet, J Clin Toxicol 2016, 6:6(Suppl)

http://dx.doi.org/10.4172/2161-0495.C1.021